The cost of ionic liquids (ILs) is a barrier to utilization in cellulosic biorefinery pretreatment. Our low-cost [HSO ₄ ] ⁻ ILs are nearly as efficient as standard [OAc] options.
No takes yet. Share an insight, caveat, or question.
George et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: